clodronic acid has been researched along with Autoimmune Thrombocytopenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, M; Hayashi, K; Kurata, Y; Mizutani, M; Nisikawa, M; Nomura, S; Saigo, K; Suehiro, A; Takubo, T; Tamaki, S; Uemura, Y | 1 |
| Chen, S; Ding, S; Li, P; Tan, Z; Zhu, Y; Zhuang, H | 1 |
| Ji, XW; Li, PY; Tan, ZH; Wu, ZY; Zhu, YH | 1 |
| Alves-Rosa, F; Cabrera, J; Isturiz, MA; Palermo, MS; Stanganelli, C; van Rooijen, N | 1 |
4 other study(ies) available for clodronic acid and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
[Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies | 2005 |
Targeting study of gelatin adsorbed clodronate in reticuloendothelial system and its potential application in immune thrombocytopenic purpura of rat model.
Topics: Analgesics, Non-Narcotic; Animals; Clodronic Acid; Colloids; Drug Carriers; Drug Delivery Systems; Excipients; Gelatin; Immunity, Cellular; Immunosuppressive Agents; Isotope Labeling; Liver; Macrophages; Male; Mononuclear Phagocyte System; Nanotubes; Phytic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Rats; Rats, Sprague-Dawley; Spleen; Technetium; Tissue Distribution | 2006 |
[Experimental study for thrombocytopenic purpura therapy by targeting macrophages in liver and spleen].
Topics: Animals; Clodronic Acid; Drug Carriers; Drug Delivery Systems; Gelatin; Liver; Macrophages; Particle Size; Purpura, Thrombocytopenic, Idiopathic; Rabbits; Rats; Rats, Sprague-Dawley; Spleen | 2007 |
Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model.
Topics: Animals; Autoimmune Diseases; Bleeding Time; Blood Platelets; Clodronic Acid; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation, Preclinical; Erythrocyte Count; Immune Sera; Indium Radioisotopes; Leukocyte Count; Liposomes; Liver; Macrophages; Mice; Models, Animal; Organ Specificity; Organometallic Compounds; Oxyquinoline; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Rabbits; Spleen | 2000 |